Botox, Dysport, Daxxify, Xeomin: An Honest Field Guide to Choosing Your Neurotoxin
There are four FDA-approved neurotoxins on the U.S. market, all of them quietly excellent, and all of them slightly different in ways that matter. Patients arrive at our consultations asking for "Botox" the way they ask for Kleenex — as if it were the only product in the category. It is not. And while no single neurotoxin is better than the others in any absolute sense, the differences between them are real, and the right choice for your face, your metabolism, and your goals is worth a thoughtful conversation.
Here is how a San Diego aesthetician with a decade in injectables thinks about the four.
What they all have in common
Botox, Dysport, Daxxify, and Xeomin are all formulations of botulinum toxin type A. Injected in carefully calibrated doses into specific facial muscles, they temporarily prevent those muscles from contracting fully. Less contraction means fewer dynamic wrinkles — the lines that form when you express emotion — and, over time, fewer of the static wrinkles that develop when those expressions etch themselves permanently into the skin.
All four are FDA-approved, all four are produced under pharmaceutical-grade conditions, and all four are reversible in the only sense that matters: their effect simply wears off. None of them change the underlying anatomy of your face. None of them migrate (the way filler can, when poorly placed). They are, in our hands, among the most predictable tools in aesthetic medicine.
What separates them is their molecular structure, their onset, their duration, and a handful of subtle differences in how they spread once injected. These differences are why we keep all four in the practice and why we don't believe in a one-product-fits-all approach.
Botox (onabotulinumtoxinA)
The original. FDA-approved for cosmetic use in 2002, with two decades of safety data and the largest body of clinical evidence of any neurotoxin. When patients ask for "Botox," they usually mean Botox by Allergan, and there's a reason: it built the category.
Onset: Visible softening typically begins at days 3–5, full effect at days 10–14. Duration: Three to four months for most patients in most areas. Diffusion: Moderate. Botox tends to stay relatively close to the injection site, which makes it the most predictable choice for precise areas — the area between the brows (the "11s"), the corners of the eyes (crow's feet), small-area work around the lower face.
Who it suits: Almost everyone. Botox is our default for first-time patients, for patients who want a known quantity, and for any work that requires the predictability of well-controlled diffusion. If you've had Botox before and loved your result, there is rarely a reason to switch.
Dysport (abobotulinumtoxinA)
Approved in the U.S. in 2009, longer history in Europe. Slightly smaller molecule with a wider field of diffusion.
Onset: Faster than Botox — many patients see softening at 24–48 hours, full effect by day 7. Duration: Comparable to Botox; three to four months, with some patients reporting a slightly longer window. Diffusion: Wider. This is its defining characteristic. Dysport spreads further from the injection point, which makes it ideal for broader areas where smooth, even softening matters — the forehead, in particular, often takes Dysport beautifully because the wider diffusion produces a smoother result with fewer "speed bumps."
Who it suits: Patients who want to see results faster (the bride three weeks out who didn't pre-plan; the patient with an event in ten days), patients with broader forehead concerns, and patients who have responded well to Dysport in the past. Patients who've developed any clinical resistance to Botox sometimes do better on Dysport because the protein structure is slightly different.
Daxxify (daxibotulinumtoxinA)
The newest entrant — FDA-approved in 2022 — and the most disruptive product in the category in twenty years. Daxxify uses a stabilizing peptide rather than the human serum albumin used by other neurotoxins, and the result is meaningfully longer-lasting.
Onset: Comparable to Botox; effect at days 5–7, full result by days 10–14. Duration: This is the headline. Median duration is six months, with some patients reporting effect for nine months or more. For comparison: Botox at four months, Dysport at four months, Daxxify at six. Diffusion: Moderate, similar to Botox.
Who it suits: Patients who hate the cadence of quarterly injections — busy professionals, patients who travel constantly, patients who simply want to think about Botox half as often. Patients who metabolize Botox unusually quickly and find themselves "out" at month two and a half.
A note of nuance: Longer duration sounds purely good, but it has a flip side. If you don't love your result — say, a brow position that didn't quite settle the way you wanted — you wait six months for it to wear off, not three. We tend to introduce Daxxify only after a patient has established a stable response with Botox or Dysport so we know how their face metabolizes neurotoxin generally.
Xeomin (incobotulinumtoxinA)
The "naked" neurotoxin. Xeomin is a purified formulation that contains only the active botulinum toxin, with the surrounding accessory proteins removed during manufacturing.
Onset: Comparable to Botox; days 3–5 for visible effect, full result by day 14. Duration: Three to four months, similar to Botox. Diffusion: Moderate, similar to Botox.
Who it suits: Patients with a documented or suspected resistance to Botox or Dysport. Because Xeomin lacks the accessory proteins that the immune system can occasionally form antibodies to, it remains effective in the small subset of patients whose bodies have started to neutralize other neurotoxins. We also reach for Xeomin in patients who simply prefer a "purer" formulation — the appeal is partly clinical and partly personal.
How we actually choose at Skin Haven
The decision isn't a product comparison chart. It's a conversation about your face, your timeline, and your past experience.
For a first-time patient with a typical concern, we lean Botox. The predictability matters; the safety data matters; we want to learn how your face responds before we get more creative.
For a patient with a wide forehead, Dysport's diffusion can produce a more even, natural-looking softening than Botox in the same area.
For a bride or event-prep patient on a tight timeline, Dysport buys us a few extra days of onset.
For a busy patient who hates coming in every twelve weeks, Daxxify's duration is genuinely life-improving once we've established a stable dosing pattern.
For a patient who has plateaued on her usual product, Xeomin or a switch between Botox and Dysport can break the resistance.
For most patients, in most appointments, the difference between products is smaller than the difference between injectors. A skilled injector with Botox will produce a better result than an unskilled injector with the most expensive new product on the market. The product matters; the hand matters more.
What never matters as much as patients think
The brand on the syringe will not, by itself, give you a more "natural" or "frozen" result. The unit count is not directly comparable across products (a unit of Dysport is not a unit of Botox; the conversion is roughly 2.5 to 1, which is why pricing comparisons by unit are misleading). And the marketing language around each brand — "advanced," "next-generation," "luxury" — is exactly that: marketing.
What matters is the diagnosis. Where are the lines forming? What's the underlying muscle pattern? What does your face look like at rest, in expression, in laughter? What did your last treatment do well, and where did it fall short? A thoughtful injector spends most of the consultation looking at your face and asking those questions, then chooses the product, the dosing, and the placement to match.
The practical bottom line
If you are happy with your current neurotoxin, stay with it. There is no clinical reason to switch a working protocol.
If you've never had neurotoxin and are choosing your first product, Botox or Dysport are both excellent starting points; we'll guide you in consultation based on your concerns and timeline.
If you've been getting injections for years and feel your results have shortened, fluttered, or become unpredictable, the conversation worth having is whether to switch products, switch dosing, or switch the injection plan altogether. Sometimes the answer is a different molecule. Sometimes the answer is a different placement strategy with the molecule you've always used.
There is no winner among the four. There is only the right tool for your face, your schedule, and your goals — and the right injector to choose it with you.
Curious which neurotoxin is right for you — or whether your current product is still serving you? Book a consultation at Skin Haven and we'll walk through your options, no commitment required.
Editorial & Medical Disclaimer
The content published on the Skin Haven journal is intended for informational and educational purposes only. It is not intended as, and should not be construed as, medical advice, diagnosis, or treatment. Reading this content does not establish a provider-patient relationship between you and Skin Haven Aesthetics & Wellness or any of its practitioners.
Aesthetic and wellness treatments — including injectables, biostimulators, microneedling, chemical peels, IV therapy, NAD+ therapy, weight loss medications, and PRP — carry inherent risks and may not be appropriate for every patient. Individual results vary based on genetics, skin condition, medical history, lifestyle, adherence to aftercare, and other factors. Any decision to pursue treatment should be made in consultation with a qualified, licensed healthcare provider after a thorough evaluation of your individual medical history, current medications, and treatment goals.
Skin Haven Aesthetics & Wellness operates in compliance with applicable California law, including the California Business and Professions Code, the regulations of the Medical Board of California, and the regulations of the Board of Registered Nursing. All medical aesthetic services involving prescription medications, injectables, or procedures regulated as the practice of medicine are performed by or under the supervision of Dr. Ronald Chao, MD, our supervising physician, in accordance with California's standardized procedures and good-faith examination requirements.
Statements regarding treatment outcomes, durations, and protocols reflect general clinical experience and published research; they are not guarantees of any specific result. Treatment timelines referenced in this content (for example, "results visible at 12 weeks") describe typical ranges observed in clinical practice, not promises applicable to any individual patient.
Brand names referenced in this content — including but not limited to Botox®, Dysport®, Daxxify®, Xeomin®, Sculptra®, Restylane®, Juvederm®, RHA®, Belotero®, Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, and Zepbound® — are the registered trademarks of their respective manufacturers. References to these products are made for educational and comparative purposes and do not imply endorsement, sponsorship, or affiliation between those manufacturers and Skin Haven Aesthetics & Wellness.
If you are experiencing a medical emergency, call 911 or seek immediate care from a qualified emergency provider. For non-emergency questions about a treatment you have received or are considering, please contact Skin Haven directly or consult your primary care provider.
© Skin Haven Aesthetics & Wellness. All content is the property of Skin Haven and may not be reproduced without permission.
